Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.045 CAD
Market Cap: 4.4m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of VPH.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VPH Intrinsic Value
Not Available
Base Case Scenario
Compare VPH to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VPH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Valeo Pharma Inc

Current Assets 19.1m
Cash & Short-Term Investments 7.1m
Receivables 4.8m
Other Current Assets 7.2m
Non-Current Assets 13.1m
PP&E 2.5m
Intangibles 10.7m
Current Liabilities 69.9m
Accounts Payable 18.7m
Short-Term Debt 3.4m
Other Current Liabilities 47.8m
Non-Current Liabilities 25.3m
Long-Term Debt 24.4m
Other Non-Current Liabilities 880k
Efficiency

Free Cash Flow Analysis
Valeo Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Valeo Pharma Inc

Revenue
53.4m CAD
Cost of Revenue
-44.6m CAD
Gross Profit
8.8m CAD
Operating Expenses
-27.9m CAD
Operating Income
-19.1m CAD
Other Expenses
-13m CAD
Net Income
-32.1m CAD
Fundamental Scores

VPH Profitability Score
Profitability Due Diligence

Valeo Pharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
Positive 3Y Average ROE
Operating Margin is Increasing
Net Margin is Increasing
32/100
Profitability
Score

Valeo Pharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

VPH Solvency Score
Solvency Due Diligence

Valeo Pharma Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
21/100
Solvency
Score

Valeo Pharma Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VPH Price Targets Summary
Valeo Pharma Inc

There are no price targets for VPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Valeo Pharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y